A new study from McMaster University has found that women who use selective serotonin reuptake inhibitor antidepressants (SSRIs) such as Zoloft during pregnancy may be putting their children at an increased risk of Type 2 diabetes and obesity. The study showed that the SSRI antidepressant led to increased fat and liver inflammation among women who took the drug during pregnancy.
Diabetes and obesity are just a few of the side effects from antidepressants facing women and their children. Several studies have found severe birth defects associated with Zoloft, including persistent pulmonary hypertension of the newborn (PPHN), the risk for which increases 6 times when a woman takes Zoloft during the third trimester of pregnancy.
Multiple women have filed lawsuits against manufacturer Pfizer alleging that the company failed to warn doctors and patients of the increased risks of birth defects associated with Zoloft. Women have alleged the drug caused severe birth defects, including heart defects, brain defects, anencephaly and omphalocele.